Skip to main content
. 2016 Jul 30;11(1):26. doi: 10.1007/s11657-016-0280-5

Table 2.

Risk factors predictive of imminent risk for fracture (OR > 1) at any fracture site

Predictor 12 months prefracture
OR (95 % CI)
P value 24 months prefracture
OR (95 % CI)
P value
Demographic and general health characteristics
 History of falls 6.67 (6.03–7.37) <0.0001 4.43 (4.09–4.80) <0.0001
 Every additional decade after age 50 years 2.00 (1.98–2.03) <0.0001 1.97 (1.94–2.00) <0.0001
Comorbidities
 CNS disease 1.41 (1.30–1.52) <0.0001 1.34 (1.25–1.43) <0.0001
 Psychoses 1.37 (1.26–1.48) <0.0001 1.34 (1.25–1.44) <0.0001
 Alzheimer’s disease 1.35 (1.22–1.50) <0.0001 1.25 (1.14–1.37) <0.0001
General health status measures
 DCIa
  ≥4 1.46 (1.35–1.59) <0.0001 1.49 (1.38–1.62) <0.0001
  3 1.40 (1.31–1.50) <0.0001 1.42 (1.32–1.52) <0.0001
  2 1.26 (1.19–1.32) <0.0001 1.29 (1.22–1.36) <0.0001
  1 1.16 (1.12–1.20) <0.0001 1.17 (1.13–1.22) <0.0001
Concomitant medications
 Narcotics 2.11 (2.05–2.18) <0.0001 1.85 (1.79–1.92) <0.0001
 Antidepressants—SSRIs 1.47 (1.41–1.52) <0.0001 1.41 (1.36–1.46) <0.0001
 Muscle relaxants 1.40 (1.34–1.47) <0.0001 1.29 (1.25–1.35) <0.0001
 Tranquilizers 1.29 (1.18–1.40) <0.0001 1.24 (1.15–1.34) <0.0001
 Antidepressants—other 1.27 (1.21–1.33) <0.0001 1.22 (1.16–1.27) <0.0001
 Anti-Parkinson 1.24 (1.15–1.35) <0.0001 1.20 (1.11–1.29) <0.0001
 Antidepressants—tricyclics 1.09 (1.02–1.17) 0.0119 NS
 Sedatives and sleep aids, excluding benzodiazepines 1.05 (1.00–1.11) 0.0376 1.08 (1.03–1.12) 0.0010
Mobility/frailty
 Wheelchair use 1.79 (1.61–2.00) <0.0001 1.80 (1.64–1.97) <0.0001
 Mobility impairment 1.46 (1.41–1.51) <0.0001 1.39 (1.34–1.43) <0.0001
 Home healthcare 1.24 (1.16–1.34) <0.0001 1.20 (1.13–1.28) <0.0001
 Nursing home 1.19 (1.12–1.28) <0.0001 1.19 (1.13–1.26) <0.0001

Risk factors with OR > 1 and significant (P < 0.05) included on table

CNS central nervous system, DCI Deyo-Charlson Comorbidity Index, NS nonsignificant, OR odds ratio, SSRI selective serotonin reuptake inhibitor

aReference group: 0